Biora Therapeutics (NASDAQ:BIOR) Trading Down 11.6% – Here’s Why

Biora Therapeutics, Inc. (NASDAQ:BIOR) shares fell 11.6% during trading on Monday . The stock traded as low as $0.42 and last traded at $0.53. 18,311 shares were traded during mid-day trading, a decline of 68% from the average session volume of 57,403 shares. The stock had previously closed at $0.60.

Analysts Set New Price Targets

Separately, HC Wainwright boosted their target price on shares of Biora Therapeutics from $15.00 to $23.00 and gave the stock a “buy” rating in a research report on Monday, November 18th.

Biora Therapeutics Price Performance

The business’s 50-day simple moving average is $2.37 and its 200-day simple moving average is $5.01. The company has a market cap of $2.40 million, a price-to-earnings ratio of -0.04 and a beta of 1.12.

Biora Therapeutics Company Profile

Biora Therapeutics, Inc, a clinical-stage biotechnology company, engages in developing oral biotherapeutics in the United States. The company offers NaviCap, a targeted oral delivery platform for delivery of therapeutics in the gastrointestinal tract to enhance the treatment of inflammatory bowel diseases; and BioJet, a systemic oral delivery platform designs to replace injection with needle-free, oral delivery of large molecules for management of chronic diseases.